• Je něco špatně v tomto záznamu ?

Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites

X. Gu, L. Boldrup, PJ. Coates, R. Fahraeus, E. Nylander, C. Loizou, K. Olofsson, L. Norberg-Spaak, O. Gärskog, K. Nylander,

. 2016 ; 6 (-) : 32579. [pub] 20160830

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18025320

Epigenetic modifications are essential regulators of biological processes. Decreased DNA methylation of OAS2 (2'-5'-Oligoadenylate Synthetase 2), encoding an antiviral protein, has been seen in psoriasis. To provide further insight into the epigenetic regulation of OAS2, we performed pyrosequencing to detect OAS2 DNA methylation status at 11 promoter and first exon located CpG sites in psoriasis (n = 12) and two common subtypes of squamous cell carcinoma (SCC) of the head and neck: tongue (n = 12) and tonsillar (n = 11). Compared to corresponding controls, a general hypomethylation was seen in psoriasis. In tongue and tonsillar SCC, hypomethylation was found at only two CpG sites, the same two sites that were least demethylated in psoriasis. Despite differences in the specific residues targeted for methylation/demethylation, OAS2 expression was upregulated in all conditions and correlations between methylation and expression were seen in psoriasis and tongue SCC. Distinctive methylation status at four successively located CpG sites within a genomic area of 63 bp reveals a delicately integrated epigenetic program and indicates that detailed analysis of individual CpGs provides additional information into the mechanisms of epigenetic regulation in specific disease states. Methylation analyses as clinical biomarkers need to be tailored according to disease-specific sites.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025320
003      
CZ-PrNML
005      
20180710093711.0
007      
ta
008      
180709s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/srep32579 $2 doi
035    __
$a (PubMed)27572959
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Gu, Xiaolian $u Department of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden.
245    10
$a Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites / $c X. Gu, L. Boldrup, PJ. Coates, R. Fahraeus, E. Nylander, C. Loizou, K. Olofsson, L. Norberg-Spaak, O. Gärskog, K. Nylander,
520    9_
$a Epigenetic modifications are essential regulators of biological processes. Decreased DNA methylation of OAS2 (2'-5'-Oligoadenylate Synthetase 2), encoding an antiviral protein, has been seen in psoriasis. To provide further insight into the epigenetic regulation of OAS2, we performed pyrosequencing to detect OAS2 DNA methylation status at 11 promoter and first exon located CpG sites in psoriasis (n = 12) and two common subtypes of squamous cell carcinoma (SCC) of the head and neck: tongue (n = 12) and tonsillar (n = 11). Compared to corresponding controls, a general hypomethylation was seen in psoriasis. In tongue and tonsillar SCC, hypomethylation was found at only two CpG sites, the same two sites that were least demethylated in psoriasis. Despite differences in the specific residues targeted for methylation/demethylation, OAS2 expression was upregulated in all conditions and correlations between methylation and expression were seen in psoriasis and tongue SCC. Distinctive methylation status at four successively located CpG sites within a genomic area of 63 bp reveals a delicately integrated epigenetic program and indicates that detailed analysis of individual CpGs provides additional information into the mechanisms of epigenetic regulation in specific disease states. Methylation analyses as clinical biomarkers need to be tailored according to disease-specific sites.
650    _2
$a 2',5'-oligoadenylátsynthetasa $x genetika $x metabolismus $7 D015088
650    _2
$a spinocelulární karcinom $x genetika $x metabolismus $x patologie $7 D002294
650    _2
$a studie případů a kontrol $7 D016022
650    12
$a CpG ostrůvky $7 D018899
650    _2
$a metylace DNA $7 D019175
650    12
$a epigeneze genetická $7 D044127
650    _2
$a nádory hlavy a krku $x genetika $x metabolismus $x patologie $7 D006258
650    _2
$a lidé $7 D006801
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a psoriáza $x genetika $x metabolismus $x patologie $7 D011565
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a nádory jazyka $x genetika $x metabolismus $x patologie $7 D014062
650    _2
$a tonzilární nádory $x genetika $x metabolismus $x patologie $7 D014067
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Boldrup, Linda $u Department of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden.
700    1_
$a Coates, Philip J $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
700    1_
$a Fahraeus, Robin $u Department of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden. RECAMO, Masaryk Memorial Cancer Institute, Brno, Czech Republic. Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, Paris, France.
700    1_
$a Nylander, Elisabet $u Department of Public Health and Clinical Medicine/Dermatology and Venereology, Umeå University, Umeå, Sweden.
700    1_
$a Loizou, Christos $u Department of Clinical Sciences/ENT, Umeå University, Umeå, Sweden.
700    1_
$a Olofsson, Katarina $u Department of Clinical Sciences/ENT, Umeå University, Umeå, Sweden.
700    1_
$a Norberg-Spaak, Lena $u Department of Clinical Sciences/ENT, Umeå University, Umeå, Sweden.
700    1_
$a Gärskog, Ola $u Department of Clinical Sciences/ENT, Umeå University, Umeå, Sweden.
700    1_
$a Nylander, Karin $u Department of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 6, č. - (2016), s. 32579
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27572959 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180710094000 $b ABA008
999    __
$a ok $b bmc $g 1317451 $s 1022241
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 6 $c - $d 32579 $e 20160830 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace